Reasonable price and strategic priority, BioSim request for electro-intensive pharmaceutical industries

In the context of the measures to rationalize energy consumption, BioSim values ​​positively the protection that is going to be established for industries related to the drug value chain, and also proposes mechanisms that allow the price of certain products to be modified in a timely manner. Off-patent medicines whose profitability may be compromised by unexpected inflationary situations.

READ MORE